Document text
Principal Investigator: Yogesh K Gupta
Organization: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Fiscal Year: 2024
Award: $584,674
Funding agency: National Institute of Allergy and Infectious Diseases
Modified Project Summary/Abstract Section
The massive global pandemic with high morbidity and mortality makes Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) one of the deadliest viruses in recent history. It is especially noteworthy for hijacking the normal operations of human cells. To develop effective therapies, we need a better understanding of the mechanisms that permit the virus to invade cells and evade host immune restriction. SARS-CoV-2 encodes the non-structural protein (nsp)16/nsp10 protein complex that transfers a methyl group from S-adenosyl methionine (SAM) to 2’-OH of the first transcribing nucleotide of the viral mRNA and thus converts the Cap-0 (m7GpppA) to Cap-1 (m7GpppAm). The resulting viral mRNA mimics host cell’s mRNA. In this way, a cell cannot distinguish between its own RNA and that of the virus. This modification of the virally encoded mRNA not only tricks the immune system and helps the virus to take over the host translation machinery for synthesis of its own proteins for survival and propagation. Ablation of nsp16 activity should trigger an immune response to viral infection and limit pathogenesis. Our recent paper in Nature Communications described atomic level details of the nsp16/nsp10 complex and how the enzyme is well adapted to bind the RNA cap and exert the 2’-OH methylation. We also discovered a distant pocket (located 25Å away from the catalytic center) in nsp16 that is unique to SARS-CoV-2. We also found that this pocket in nsp16 is partially composed of amino acids that are unique to SARS-CoV-
2. It can bind small molecules outside of the catalytic center. We propose to build a long-term research program aimed at deciphering the factors crucial to the maintenance of RNA genome and evasion from the host’s immune response. Our studies will reveal basic principles underlying SARS-CoV-2 RNA cap modification, the mode of nucleoprotein (NP) assembly, interplay with mRNA, and new approaches for therapeutic targeting. In Aim 1, we will resolve a series of new structures of nsp16/nsp10 proteins captured in every step of the methyl transfer by X-ray crystallography. The structural data will be validated by detailed biochemical and biophysical studies. We will resolve the biochemical and structural determinants of the assembly of viral RNA capping machinery, and identify factors underlying integrity of RNA genome. In Aim 2, we will develop a novel molecular tool to study temporal distribution of the RNA methylation during viral infection. We will examine new models for combinatorial inhibition of viral proteins by drug repurposing or novel small molecules. These small molecules will also be tested against other viruses, such as Ebola, Lassa, and MPox, for their broad utility as pan-antivirals. Finally, we will use our recently established reverse genetics approaches based on the use of a bacterial artificial chromosome (BAC) to generate recombinant (r)SARS-CoV2 containing mutations in nsp16 to determine their contribution in viral replication in cultured cells and pathogenesis in vivo using our recently described K18 human angiotensin converting enzyme 2 (hACE2) mouse model of SARS-CoV-2 infection and associated coronavirus disease 2019 (COVID-19).
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><5' Capped RNA><5' mRNA Cap Structure><ACE2><AI system><Ablation><Active Sites><Address><Ademetionine><AdoMet><Amino Acids><Anti-viral Agents><Architecture><Artificial Intelligence><Assay><BAC clone><BACs><Bacterial Artificial Chromosomes><Bats><Binding><Bioassay><Biochemical><Biological Assay><Biology><Biophysics><COVID-19><COVID-19 infection><COVID-19 therapeutics><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID-19 virus infection><COVID19 infection><COVID19 virus><CV-19><Cell Body><Cells><Chiroptera><CoV-2><CoV2><Communication><Complex><Computer Reasoning><ConvNet><Coronaviridae><Coronavirus><Coronavirus Infectious Disease 2019><Crystallization><Cultured Cells><Dangerousness><Data><Disease><Disorder><Distant><Ebola><Economics><Engineering / Architecture><Enzyme Gene><Enzymes><Epidemiological data><Epidemiology data><Future><Gene Transcription><Generalized Growth><Genetic Alteration><Genetic Change><Genetic Transcription><Genetic defect><Genome><Genomic approach><Growth><Health><History><Human><Immune><Immune Evasion><Immune response><Immune system><Immunes><Immunological response><Individual><Infection><Innate Immune Response><Invaded><Investigation><K-18><K-18 conjugate><K18><K18 combination><Lassa><Length><Libraries><Life Cycle><Life Cycle Stages><Machine Intelligence><Maintenance><Maps><Messenger RNA><Methods><Methylation><Mice><Mice Mammals><Modeling><Modern Man><Modification><Molecular><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><Monkey Pox><Monkeypox><Morbidity><Morbidity - disease rate><Murine><Mus><Mutation><Nature><Non-Polyadenylated RNA><Non-structural Protein><Nonstructural Protein><Nucleoproteins><Nucleotides><Organism><Paper><Pathogenesis><Property><Proteins><Publishing><RNA><RNA Binding><RNA Caps><RNA Degradation><RNA Expression><RNA Folding><RNA Gene Products><RNA Processing><RNA Viruses><RNA bound><RNA chemical synthesis><RNA methylation><RNA synthesis><Recombinants><Recording of previous events><Reporting><Research><Ribonucleic Acid><S-Adenosylhomocysteine><S-Adenosylmethionine><S-adenosyl methionine><S-adenosyl-methionine><SAMe><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV-2 inhibitor><SARS-CoV-2 therapeutics><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV2><SARS-CoV2 infection><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 therapeutics><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Series><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 inhibitor><Severe acute respiratory syndrome coronavirus 2 therapeutics><Severe acute respiratory syndrome related corona virus 2><Single Crystal Diffraction><Solid><Specificity><Structure><Structure-Activity Relationship><Surface><Technology><Testing><Time><Tissue Growth><Transcription><Translations><UTRs><Untranslated Regions><Viral><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral Genome><Viral Pathogenesis><Viral Proteins><Virion><Virus><Virus Assembly><Virus Diseases><Virus Particle><Virus Replication><Wuhan coronavirus><X Ray Crystallographies><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray/Neutron Crystallography><Xray Crystallography><aminoacid><analog><angiotensin converting enzyme 2><angiotensin converting enzyme II><anti-viral compound><anti-viral drugs><anti-viral medication><anti-viral therapeutic><anti-virals><beta CoV><beta coronavirus><betaCoV><betacoronavirus><biophysical analysis><biophysical foundation><biophysical principles><biophysical sciences><biophysical studies><block SARS-CoV-2><block severe acute respiratory syndrome coronavirus 2><chemical library><chemical structure function><combinatorial><conformation><conformational><conformational state><conformationally><conformations><convolutional network><convolutional neural nets><convolutional neural network><corona virus><coronavirus disease 2019><coronavirus disease 2019 infection><coronavirus disease 2019 therapeutics><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><develop a vaccine><develop vaccines><development of a vaccine><drug candidate><drug repositioning><drug repurposing><economic><effective therapy><effective treatment><emergent virus><emerging virus><epidemiologic data><genetic approach><genetic strategy><genome mutation><genomic effort><genomic strategy><hCoV19><histories><host response><immune evasive><immune system response><immunoresponse><improved><in vitro testing><in vivo><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><inhibit SARS-CoV-2><inhibit severe acute respiratory syndrome coronavirus 2><innovate><innovation><innovative><life course><living system><mRNA><methyl group><mortality><mouse model><mpox><murine model><nCoV2><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><ontogeny><operation><operations><pandemic><pandemic disease><programs><protein complex><public health relevance><repurposing agent><repurposing medication><reverse genetics><s-adenosyl-l-methionine><screening><screenings><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><severe acute respiratory syndrome-CoV><small molecule><small molecule libraries><stem><structural determinants><structural factors><structure function relationship><therapeutic target><therapeutics against COVID-19><therapeutics against SARS-CoV-2><therapeutics against SARS-coronavirus-2><therapeutics against Severe acute respiratory syndrome coronavirus 2><therapeutics against coronavirus disease 2019><therapeutics for novel coronavirus><tool><transcriptomics><translation><treat COVID-19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><vaccine development><viral RNA><viral assembly><viral emergence><viral infection><viral multiplication><viral replication><virus RNA><virus genome><virus infection><virus multiplication><virus pathogenesis><virus protein><virus-induced disease><β CoV><β coronavirus><βCoV>